| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |